Sera Prognostics, Inc. (SERA)
2.01
-0.07
(-3.37%)
USD |
NASDAQ |
Sep 02, 16:00
2.01
0.00 (0.00%)
After-Hours: 20:00
Sera Prognostics Cash from Investing (Quarterly) : 6.394M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.394M |
| March 31, 2026 | 8.985M |
| December 31, 2025 | 5.89M |
| September 30, 2025 | 5.169M |
| June 30, 2025 | 5.241M |
| March 31, 2025 | -44.80M |
| December 31, 2024 | 7.385M |
| September 30, 2024 | 4.898M |
| June 30, 2024 | 5.149M |
| March 31, 2024 | -5.689M |
| December 31, 2023 | 0.374M |
| September 30, 2023 | -15.16M |
| June 30, 2023 | 12.91M |
| Date | Value |
|---|---|
| March 31, 2023 | 2.32M |
| December 31, 2022 | -1.578M |
| September 30, 2022 | -6.296M |
| June 30, 2022 | -1.209M |
| March 31, 2022 | 14.63M |
| December 31, 2021 | -14.43M |
| September 30, 2021 | -68.00M |
| June 30, 2021 | -0.085M |
| March 31, 2021 | -0.041M |
| December 31, 2020 | -0.044M |
| September 30, 2020 | -0.083M |
| June 30, 2020 | -0.014M |
| March 31, 2020 | -0.008M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -3.20M |
| BioRestorative Therapies, Inc. | 0.9684M |
| CareDx, Inc. | 280.59M |
| Natera, Inc. | -63.43M |
| Exagen, Inc. | -0.543M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.311M |
| Cash from Financing (Quarterly) | 0.14M |
| Free Cash Flow | -28.18M |
| Free Cash Flow Per Share (Quarterly) | -0.1261 |
| Free Cash Flow to Equity (Quarterly) | -6.859M |
| Free Cash Flow to Firm (Quarterly) | -6.361M |
| Free Cash Flow Yield | -28.01% |